Nevro Corp. (NVRO)
NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 01:23PM EDT. Market open.
| Previous close | 12.79 |
| Open | 12.83 |
| Bid | 12.84 x 800 |
| Ask | 12.85 x 900 |
| Day's range | 12.70 - 13.30 |
| 52-week range | 11.98 - 34.86 |
| Volume | |
| Avg. volume | 457,479 |
| Market cap | 472.456M |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.56 |
| Earnings date | 07 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 17.47 |
PR NewswireNevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
Nevro Corp. (NYSE: NVRO), a global medical device company delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that it will release its financial results for the first quarter of 2024 after the market closes on Tuesday, May 7, 2024. The company will also host a conference call beginning at 1:30 p.m. PDT (4:30 p.m. EDT) to discuss its financial results.
ZacksAbbott (ABT) Expands in Canada With First Eterna SCS Use
Abbott's (ABT) Eterna SCS system reduces pain without causing discomfort. It leverages the BurstDR stimulation technology.
- Zacks
Here's Why You Should Retain Nevro (NVRO) Stock for Now
Strength in Nevro's (NVRO) Senza Platform raises optimism about the stock.
© 2024 Yahoo. All rights reserved.